Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

Clinical trial NCT05874414 · RECRUITING

Trial details

NCT number: NCT05874414
Sponsor: Genfit
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma

Start date: 2023-08-21
Primary completion: 2027-12-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.